Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,029 | -2,429 | -9,547 | -7,146 | -4,900 |
| Depreciation Amortization | 23 | 10 | 30 | 21 | 14 |
| Accounts receivable | 3 | -8 | -29 | -48 | -25 |
| Other Working Capital | 23 | 103 | -37 | 170 | 78 |
| Other Operating Activity | 3,927 | 1,328 | 5,299 | 3,928 | 2,784 |
| Operating Cash Flow | $-2,053 | $-996 | $-4,284 | $-3,075 | $-2,049 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26 | -19 | -29 | -9 | N/A |
| Investing Cash Flow | $-26 | $-19 | $-29 | $-9 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 853 | 770 | 2,049 | 1,516 | 475 |
| Common Stock Issued | 529 | 168 | 1,414 | 926 | 153 |
| Common Stock Repurchased | N/A | N/A | -40 | -40 | -40 |
| Other Financing Activity | 357 | 0 | -50 | 0 | 0 |
| Financing Cash Flow | $1,739 | $938 | $3,373 | $2,402 | $588 |
| Exchange Rate Effect | 1 | 8 | 20 | 24 | -16 |
| Beginning Cash Position | 990 | 990 | 1,910 | 1,910 | 1,910 |
| End Cash Position | 651 | 921 | 990 | 1,252 | 434 |
| Net Cash Flow | $-339 | $-69 | $-920 | $-658 | $-1,477 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,053 | -996 | -4,284 | -3,075 | -2,049 |
| Capital Expenditure | -26 | -19 | -29 | -9 | N/A |
| Free Cash Flow | -2,079 | -1,015 | -4,313 | -3,084 | -2,049 |